Company Overview
Growth Strategy
Highlights.
COMMERCIAL
Global
Expansion.
Investment focused on wholesale and
distribution partnerships for rapid scale of
both CPG and cannabis sales in key markets.
Multiple cannabis sale agreements signed
from markets around the globe. GMP
compliant and certified facilities allow for
access to both recreational and medical
markets.
STRICTLY PRIVATE AND CONFIDENTIAL
BRANDS
Global
House of Brands.
Owned relationship with end consumers.
High margin business that allows for
rapid product/market fit testing and
launch. Over 600+ products and 70+
medical, cosmetic licenses, and
16,500+ points of distribution across
LATAM and U.S. with sales across 13
other countries.
LIFE SCIENCES
Clinical
Research.
All-natural, organic, ancient medicine, brought
into the 21st century. Owned labs and dedicated
team to uncover cannabis untapped potential as
a therapeutic. Two clinical trials set to begin
University of Manchester and Colombian
based - leveraging patent-pending formulation.
Flora Pharma division is led by renowned
neuroscientist, Dr. Annabelle Manalo-Morgan.
GROWTH STRATEGY HIGHLIGHTS
FLORA GROWTH
7View entire presentation